< Back to Portfolio

Constructive Bio

Global leader in genetic code expansion.

  • company-website-icon
  • company-linkedin-icon
  • company-twitter-icon

About

Constructive Bio is leveraging the world’s first fully synthetic genome with expanded genetic code to build biomolecules never before possible. They are the global leader in genetic code expansion and the use of novel building blocks of biomolecules to develop better medicines, enzymes, and biomaterials.

  • Location: Cambridge, UK
  • Paladin Initial Investment Date: September 2024

Portfolio Stats

Over 75 Companies

Paladin has invested in over 75 portfolio companies since 2001.

4 Continents

Paladin has invested in companies in North America, Australia, Europe, and South America.

Over $2 billion

Paladin was founded in 2001 and has since managed over $2B of companies and assets.